Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP TEVAR PIS
NCT07328906Not yet recruiting
- Sponsor
- University of Belgrade
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylprednisolone injection in Post-implantation syndrome (PIS) (2 arms), sponsored by University of Belgrade. Primary endpoint: Incidence of Postimplantation Syndrome at 5 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
Post-implantation syndrome (PIS)
Beyond the preview
Go deeper on NCT07328906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07328906.